{"log_id": 5055630280197586240, "direction": 0, "words_result_num": 45, "words_result": [{"probability": {"variance": 0.046266, "average": 0.84521, "min": 0.392647}, "location": {"width": 180, "top": 237, "height": 36, "left": 242}, "words": "香豆素衍物"}, {"probability": {"variance": 0.007702, "average": 0.980203, "min": 0.451056}, "location": {"width": 1087, "top": 258, "height": 61, "left": 242}, "words": "在一项健康志愿者和另一项高胆固醇血症病人参加的临床研究中,服用辛伐他汀20~"}, {"probability": {"variance": 0.005598, "average": 0.962427, "min": 0.64829}, "location": {"width": 1139, "top": 299, "height": 66, "left": 187}, "words": "4ug/天,能中度提高香豆素类抗凝剂的抗凝效果:以凝血酶原时间国际标准化比率(INR"}, {"probability": {"variance": 0.00244, "average": 0.973934, "min": 0.776428}, "location": {"width": 1135, "top": 342, "height": 63, "left": 185}, "words": "计,健康志愿者组从基线的1.7延长到1.8秒,高胆固醇血症患者组从2.6延长到3.4秒"}, {"probability": {"variance": 0.000607, "average": 0.98768, "min": 0.897905}, "location": {"width": 1153, "top": 386, "height": 61, "left": 185}, "words": "对于使用香豆素抗凝剂的患者,应在使用辛伐他汀之前测定其凝血酶原时间,并在治疗初期"}, {"probability": {"variance": 0.012856, "average": 0.963158, "min": 0.476788}, "location": {"width": 1153, "top": 429, "height": 61, "left": 185}, "words": "经常测量,以保证凝血酶原时间无明显变化。一旦记录下稳定的凝血原时间,应建议患者"}, {"probability": {"variance": 0.00682, "average": 0.972915, "min": 0.497524}, "location": {"width": 1194, "top": 470, "height": 61, "left": 182}, "words": "在服用香豆素类抗凝剂期间定期监测凝血酶原时间。如调整辛伐他汀剂量或停药,应重复以1"}, {"probability": {"variance": 0.008228, "average": 0.971104, "min": 0.53401}, "location": {"width": 1135, "top": 513, "height": 63, "left": 189}, "words": "上步骤。对于未用香豆素抗凝剂的患者,出血或凝血酶原时间变化与服用辛伐他汀无关"}, {"probability": {"variance": 0.000297, "average": 0.988351, "min": 0.949894}, "location": {"width": 157, "top": 577, "height": 36, "left": 198}, "words": "【药物过量】"}, {"probability": {"variance": 0.006328, "average": 0.966814, "min": 0.5962}, "location": {"width": 1096, "top": 598, "height": 61, "left": 244}, "words": "有少量服药过量的报道,病人无特殊症状,所有病人均康复且无后遗症。其中最大服用"}, {"probability": {"variance": 0.006196, "average": 0.960799, "min": 0.670443}, "location": {"width": 639, "top": 650, "height": 57, "left": 191}, "words": "剂量为450g一般采取常规措施来处理服药过量"}, {"probability": {"variance": 0, "average": 0.762121, "min": 0.762121}, "location": {"width": 89, "top": 682, "height": 34, "left": 977}, "words": "过"}, {"probability": {"variance": 0.023025, "average": 0.922645, "min": 0.55972}, "location": {"width": 258, "top": 703, "height": 57, "left": 102}, "words": "行【药理毒理】"}, {"probability": {"variance": 6e-06, "average": 0.996955, "min": 0.992937}, "location": {"width": 116, "top": 751, "height": 34, "left": 189}, "words": "药理作用"}, {"probability": {"variance": 0.030865, "average": 0.915533, "min": 0.377618}, "location": {"width": 1146, "top": 767, "height": 61, "left": 248}, "words": "辛伐他汀可降低正常的和升高的低密度脂蛋白胆固醇(LDC)水平.低密度脂蛋白LD)"}, {"probability": {"variance": 0.009348, "average": 0.954981, "min": 0.53999}, "location": {"width": 1187, "top": 810, "height": 63, "left": 191}, "words": "由极低密度脂蛋白(VLDL)生成,主要通过高亲和力的LDL受体被分解谢。辛伐他汀通过降"}, {"probability": {"variance": 0.004831, "average": 0.964179, "min": 0.643376}, "location": {"width": 1158, "top": 854, "height": 63, "left": 187}, "words": "低VLDL胆固醇浓度、诱导LDL受体的生成而降低LDL,从而导致LL-C的产生减少和/或分"}, {"probability": {"variance": 0.009343, "average": 0.95358, "min": 0.582173}, "location": {"width": 1153, "top": 895, "height": 63, "left": 191}, "words": "解代谢增加。在辛伐他汀治疗期间载脂蛋白B(ApoB)也明显下降。因为每个LDL微粒含有"}, {"probability": {"variance": 0.013488, "average": 0.94487, "min": 0.421575}, "location": {"width": 1123, "top": 938, "height": 63, "left": 219}, "words": "分子ApoB,而在主要以LDLC升高(不伴随VD升高)患者别的脂蛋白中发现了很少的"}, {"probability": {"variance": 0.008408, "average": 0.962845, "min": 0.471993}, "location": {"width": 1121, "top": 982, "height": 61, "left": 194}, "words": "ApoB,提示辛伐他汀不仅可从LDL除去胆固醇,而且可降低循环LDL微粒的浓度。另外"}, {"probability": {"variance": 0.020227, "average": 0.932195, "min": 0.467241}, "location": {"width": 1153, "top": 1023, "height": 63, "left": 194}, "words": "辛伐他汀可降低VDL和甘油三酯(TG),并升高HDL-Ca辛伐他汀对脂蛋白(a)、纤维蛋白原"}, {"probability": {"variance": 9e-06, "average": 0.997369, "min": 0.990277}, "location": {"width": 561, "top": 1078, "height": 52, "left": 194}, "words": "和冠心病的其他的生化指标的影响尚不明确"}, {"probability": {"variance": 2.6e-05, "average": 0.996116, "min": 0.987381}, "location": {"width": 121, "top": 1135, "height": 31, "left": 194}, "words": "毒理研究"}, {"probability": {"variance": 0.011492, "average": 0.945053, "min": 0.491533}, "location": {"width": 1096, "top": 1148, "height": 63, "left": 253}, "words": "遗传毒性:微生物致突变实验(mes),体外大肝细胞碱洗脱分析、哺乳动物V-79细"}, {"probability": {"variance": 0.008296, "average": 0.964126, "min": 0.532988}, "location": {"width": 1155, "top": 1190, "height": 66, "left": 194}, "words": "胞正向致突变研究、体外CHO细胞染色体夹变研究或体内小鼠骨髓细胞染色体突变分析实"}, {"probability": {"variance": 0.024572, "average": 0.913741, "min": 0.538644}, "location": {"width": 386, "top": 1244, "height": 84, "left": 141}, "words": "均末发现致变作用"}, {"probability": {"variance": 0.021597, "average": 0.923102, "min": 0.36713}, "location": {"width": 1091, "top": 1276, "height": 61, "left": 258}, "words": "殖毒性:琴伐他汀大鼠每日剂量25g/kg或兔10ng/kg,未见致晴性丙剂量均为人"}, {"probability": {"variance": 0.025226, "average": 0.915784, "min": 0.380024}, "location": {"width": 1224, "top": 1324, "height": 57, "left": 127}, "words": "广舞体表面mg/m用药剂量的3倍。然而,在另一个结构相关的 I hmg-caa还原酶抑制剂"}, {"probability": {"variance": 0.0316, "average": 0.884813, "min": 0.388684}, "location": {"width": 1215, "top": 1361, "height": 68, "left": 137}, "words": "的研究中,发现六鼠和小鼠的骨骼畸形。给予辛伐他汀25mg/kg以病人剂量8mg/天的AC"}, {"probability": {"variance": 0.019486, "average": 0.95352, "min": 0.356286}, "location": {"width": 1139, "top": 1407, "height": 59, "left": 198}, "words": "计人最露体表面积用药剂量的4倍)共34周,雄性大鼠生育力降低。但在随后的一"}, {"probability": {"variance": 0.017082, "average": 0.944404, "min": 0.458796}, "location": {"width": 1226, "top": 1422, "height": 93, "left": 201}, "words": "个雄性大鼠服用同样剂量的辛伐他汀共11周(精子发育的完整周期,包括附发育成)的"}, {"probability": {"variance": 0.017604, "average": 0.947795, "min": 0.424275}, "location": {"width": 1139, "top": 1489, "height": 61, "left": 201}, "words": "生育力实验口,未观察到对生力的影响,这两个实验显微镜下均未观察到大鼠睾丸的改变"}, {"probability": {"variance": 0.0101, "average": 0.951765, "min": 0.547003}, "location": {"width": 1153, "top": 1532, "height": 61, "left": 201}, "words": "80mg/kg/天(这一剂量以体表面积计,比人用判量80mg/kg/天的最大暴体表面积用药剂"}, {"probability": {"variance": 0.012894, "average": 0.949955, "min": 0.425874}, "location": {"width": 1153, "top": 1573, "height": 61, "left": 201}, "words": "量高22倍)时观察到输精管变性(生精上皮的死和损伤),狗服月10mg/kg/天(以AUC计"}, {"probability": {"variance": 0.00416, "average": 0.983957, "min": 0.591805}, "location": {"width": 1151, "top": 1617, "height": 61, "left": 201}, "words": "约为人暴体表面积用药剂量80mg/天的2倍),可见发生与药物相关的睾丸萎缩、精子产"}, {"probability": {"variance": 0.000219, "average": 0.991555, "min": 0.950033}, "location": {"width": 881, "top": 1662, "height": 59, "left": 203}, "words": "生减少、精母细胞变性和巨细胞形成。尚不明确以上发现的临床意义"}, {"probability": {"variance": 0.000463, "average": 0.99301, "min": 0.861533}, "location": {"width": 1082, "top": 1703, "height": 57, "left": 260}, "words": "致癌性:小给予辛伐他汀25、100和400mg/kg/天,时间为72周的致癌性实验表明"}, {"probability": {"variance": 0.004088, "average": 0.981016, "min": 0.588866}, "location": {"width": 1130, "top": 1745, "height": 59, "left": 203}, "words": "平均血药浓度分别高于人口服80mg平均血药浓度的约1、4和8倍(以AUC作为总抑制活性)"}, {"probability": {"variance": 0.001288, "average": 0.985715, "min": 0.814151}, "location": {"width": 1139, "top": 1790, "height": 57, "left": 205}, "words": "在高剂量雌性组和中、高剂量雄性组,肝癌发生率显著升高,雄性组最高发生率为90%中"}, {"probability": {"variance": 0.019659, "average": 0.943597, "min": 0.377479}, "location": {"width": 1153, "top": 1829, "height": 59, "left": 205}, "words": "高剂量雌性组肝腺瘤的发生率显著升高。雌性和雄性中,高剂量肺瘤的发生率也显著升"}, {"probability": {"variance": 0.01136, "average": 0.943907, "min": 0.506361}, "location": {"width": 1153, "top": 1872, "height": 57, "left": 207}, "words": "高。高剂量雄性组与对照组相比,副泪腺(齿类动物假睛的腺体)腺瘤显著增多。25mg/kg/"}, {"probability": {"variance": 0.001235, "average": 0.986128, "min": 0.820318}, "location": {"width": 1146, "top": 1914, "height": 59, "left": 214}, "words": "天组未见对癌性的影响。小鼠给予剂量达25mg/kg/天的92周研究中,未见其致癌性作用"}, {"probability": {"variance": 0.005912, "average": 0.973787, "min": 0.603591}, "location": {"width": 1137, "top": 1955, "height": 59, "left": 221}, "words": "通过AUC算,平均血浆药物浓度高于人口服80mg辛伐他汀血药度的一倍)。大鼠给予"}, {"probability": {"variance": 0.000352, "average": 0.988623, "min": 0.919562}, "location": {"width": 1151, "top": 1996, "height": 63, "left": 210}, "words": "辛伐他汀25mg/kg/天连续两年,雌性大鼠甲状腺滤泡腺瘤的发生率有统计学意义地显著升"}, {"probability": {"variance": 0.012274, "average": 0.954229, "min": 0.365994}, "location": {"width": 1151, "top": 2041, "height": 61, "left": 210}, "words": "高,通过AUC计算,其暴露体表面积用药剂量较人服用辛伐他汀B0m高11倍。大鼠连续两"}], "language": 3}